Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mechanism-driven phase I translational study of trifluoperazine in adults with sickle cell disease

7 Nov 2013

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Transport and Resistance Mechanisms
Share to Hemoglobinopathies and Related Disorders

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 24211787
DOI: 10.1016/j.ejphar.2013.10.062

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 11 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mechanism-driven phase I translational study of trifluoperazine in adults with sickle cell diseasePMID 24211787Read ↗

Pathophysiologically based drug treatment of sickle cell diseaseSemantic proximity Read ↗

Drug Therapies for the Management of Sickle Cell DiseaseSemantic proximity Read ↗

Targeting sickle cell disease root-cause pathophysiology with small moleculesSemantic proximity Read ↗

Emerging drugs in randomized controlled trials for sickle cell disease: are we on the brink of a new era in research and treatment?Semantic proximity Read ↗

In Silico Post-screening of Anti-polymerization Agents to Treat Sickle Cell DiseaseSemantic proximity Read ↗

Osivelotor for the treatment of sickle cell diseaseSemantic proximity Read ↗

Study Protocol for a Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Desidustat Oral Tablet in Sickle Cell Disease: A Phase IIa Proof-of-Concept EvaluationSemantic proximity Read ↗

Phenotypic screening of the ReFrame Drug Repurposing Library to discover new drugs for treating sickle cell diseaseSemantic proximity Read ↗

New therapies in sickle cell diseaseSemantic proximity Read ↗

l-Glutamine for sickle cell anemia: more questions than answersSemantic proximity Read ↗

Safety and efficacy of targeted busulfan therapy in children undergoing myeloablative matched sibling donor BMT for sickle cell diseaseSemantic proximity Read ↗

Familial Haploidentical Stem Cell Transplant in Children and Adolescents With High-Risk Sickle Cell DiseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.